Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (31-40 of 621) with videos related to

Pageof 63
Sort By:
The Lancet. Rheumatology|August 15, 2025
Further progression in patients with systemic sclerosis-associated interstitial lung disease - Authors' replyAnna-Maria Hoffmann-Vold, Oliver Distler,
The Journal of Rheumatology|July 15, 2025
Personalizing Management of Systemic Sclerosis-Associated Interstitial Lung Disease: Are Autoantibodies the Key for Risk Stratification?Cosimo Bruni, Muriel Elhai, Oliver Distler
RMD Open|August 4, 2016
Treatment of systemic sclerosis: is there any hope for the future?Yannick Allanore, Marco Matucci-Cerinic, Oliver Distler
The New England Journal of Medicine|October 17, 2019
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. ReplyOliver Distler, Martina Gahlemann, Toby M Maher
Vascular Pharmacology|December 13, 2012
The Fra-2 transgenic mouse model of systemic sclerosisBritta Maurer, Jörg H W Distler, Oliver Distler
Current Opinion in Pharmacology|June 11, 2013
Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise?Milos Antic, Jörg H W Distler, Oliver Distler
Current Rheumatology Reports|November 3, 2010
Tyrosine kinase inhibitors in the treatment of systemic sclerosis: from animal models to clinical trialsNaoki Iwamoto, Jörg H W Distler, Oliver Distler
Current Opinion in Rheumatology|March 28, 2012
Innovative antifibrotic therapies in systemic sclerosisChristian Beyer, Oliver Distler, Jörg H W Distler
Swiss Medical Weekly|April 27, 2010
Are tyrosine kinase inhibitors promising for the treatment of systemic sclerosis and other fibrotic diseases?Christian Beyer, Jörg H W Distler, Oliver Distler
RMD Open|July 19, 2018
Haematopoietic stem cell transplantation in systemic sclerosisUlrich A Walker, Lesley Ann Saketkoo, Oliver Distler
Pageof 63

Showing results (31-40 of 621) with videos related to

Sort By:
Pageof 63
The Lancet. Rheumatology|August 15, 2025
Further progression in patients with systemic sclerosis-associated interstitial lung disease - Authors' replyAnna-Maria Hoffmann-Vold, Oliver Distler,
The Journal of Rheumatology|July 15, 2025
Personalizing Management of Systemic Sclerosis-Associated Interstitial Lung Disease: Are Autoantibodies the Key for Risk Stratification?Cosimo Bruni, Muriel Elhai, Oliver Distler
RMD Open|August 4, 2016
Treatment of systemic sclerosis: is there any hope for the future?Yannick Allanore, Marco Matucci-Cerinic, Oliver Distler
The New England Journal of Medicine|October 17, 2019
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. ReplyOliver Distler, Martina Gahlemann, Toby M Maher
Vascular Pharmacology|December 13, 2012
The Fra-2 transgenic mouse model of systemic sclerosisBritta Maurer, Jörg H W Distler, Oliver Distler
Current Opinion in Pharmacology|June 11, 2013
Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise?Milos Antic, Jörg H W Distler, Oliver Distler
Current Rheumatology Reports|November 3, 2010
Tyrosine kinase inhibitors in the treatment of systemic sclerosis: from animal models to clinical trialsNaoki Iwamoto, Jörg H W Distler, Oliver Distler
Current Opinion in Rheumatology|March 28, 2012
Innovative antifibrotic therapies in systemic sclerosisChristian Beyer, Oliver Distler, Jörg H W Distler
Swiss Medical Weekly|April 27, 2010
Are tyrosine kinase inhibitors promising for the treatment of systemic sclerosis and other fibrotic diseases?Christian Beyer, Jörg H W Distler, Oliver Distler
RMD Open|July 19, 2018
Haematopoietic stem cell transplantation in systemic sclerosisUlrich A Walker, Lesley Ann Saketkoo, Oliver Distler
Pageof 63